Robert E. Hoffman Esperion Therapeutics, Inc. (ESPR) insider trading activity

ESPR Quotes by TradingView

Robert E. Hoffman is Director of Esperion Therapeutics, Inc.. Currently has a direct ownership of 5,280 shares of ESPR, which is worth approximately $5,491. The most recent transaction as insider was on May 29, 2025, when has been sold 5,280 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.28K
n/a 3M change
n/a 12M change
Total Value Held $5,491

Robert E. Hoffman Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 29 2025
BUY
Grant, award, or other acquisition
-
5,280 Added 50.0%
5,280 Common Stock

Also insider at

KURA
Kura Oncology, Inc. Healthcare
Director
KTRA
Kintara Therapeutics, Inc. Healthcare
FBLG
FibroBiologics, Inc.
Director
CYDY
CytoDyn Inc. Healthcare
Chief Financial Officer
REH

Robert E. Hoffman

Director
San Diego, CA

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ESPR